H. B. Fuller (NYSE:FUL) Issues FY 2026 Earnings Guidance

H. B. Fuller (NYSE:FUL) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 4.550-4.900 for the period, compared to the consensus EPS estimate of 4.560. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Vertical Research upgraded H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday, March 27th. Wall Street Zen raised H. B. Fuller from a “hold” rating to a “buy” rating in a report on Sunday, March 29th. Weiss Ratings reissued a “hold (c)” rating on shares of H. B. Fuller in a report on Monday, December 29th. Citigroup upped their target price on H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a report on Monday, March 30th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of H. B. Fuller in a report on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, H. B. Fuller currently has an average rating of “Moderate Buy” and a consensus target price of $65.50.

H. B. Fuller Stock Up 0.2%

H. B. Fuller stock opened at $63.83 on Friday. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.15 and a current ratio of 1.92. The firm has a market capitalization of $3.48 billion, a price-to-earnings ratio of 21.07, a price-to-earnings-growth ratio of 0.84 and a beta of 1.05. H. B. Fuller has a fifty-two week low of $48.71 and a fifty-two week high of $68.63. The stock’s fifty day moving average is $61.28 and its two-hundred day moving average is $60.04.

H. B. Fuller (NYSE:FUL) last issued its quarterly earnings data on Wednesday, March 25th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.01. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The business had revenue of $770.84 million for the quarter, compared to the consensus estimate of $787.77 million. During the same period in the prior year, the business earned $0.54 earnings per share. The business’s revenue was down 2.3% on a year-over-year basis. Analysts predict that H. B. Fuller will post 4.07 EPS for the current fiscal year.

H. B. Fuller Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 19th. Stockholders of record on Thursday, February 5th were given a $0.235 dividend. This represents a $0.94 annualized dividend and a dividend yield of 1.5%. The ex-dividend date was Thursday, February 5th. H. B. Fuller’s dividend payout ratio is currently 31.02%.

Insider Activity

In related news, CEO Celeste Beeks Mastin acquired 5,170 shares of H. B. Fuller stock in a transaction dated Tuesday, April 7th. The shares were acquired at an average cost of $57.08 per share, for a total transaction of $295,103.60. Following the completion of the transaction, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at $494,883.60. The trade was a 147.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.83% of the stock is owned by corporate insiders.

Institutional Trading of H. B. Fuller

Several institutional investors and hedge funds have recently made changes to their positions in FUL. Strs Ohio purchased a new stake in shares of H. B. Fuller in the first quarter valued at $101,000. EverSource Wealth Advisors LLC lifted its position in H. B. Fuller by 129.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock worth $73,000 after buying an additional 688 shares during the period. Baird Financial Group Inc. lifted its position in H. B. Fuller by 19.6% during the second quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock worth $452,000 after buying an additional 1,232 shares during the period. Marshall Wace LLP lifted its position in H. B. Fuller by 382.1% during the second quarter. Marshall Wace LLP now owns 20,370 shares of the specialty chemicals company’s stock worth $1,225,000 after buying an additional 16,145 shares during the period. Finally, Cerity Partners LLC lifted its position in H. B. Fuller by 2.3% during the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock worth $692,000 after buying an additional 261 shares during the period. 95.93% of the stock is currently owned by hedge funds and other institutional investors.

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.